
GILEAD SCIENCES, INC. — Investor Relations & Filings
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops, and commercializes innovative medicines to address unmet medical needs. The company's primary focus is on virology, with a portfolio of transformative therapies for life-threatening diseases such as HIV/AIDS and viral hepatitis. Gilead is also expanding its impact in oncology and inflammation, maintaining a diverse pipeline of clinical programs across these key therapeutic areas. The company invests in scientific research to develop treatments for some of the world's most challenging diseases, aiming to improve the lives of patients globally.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| FORM 8-K | 2026-05-20 | English | |
| 424B5 | 2026-05-18 | English | |
| FWP | 2026-05-14 | English | |
| 424B5 | 2026-05-14 | English | |
| Regulatory Filings 2026 | 2026-05-08 | English | |
| S-8 - GILEAD SCIENCES, INC. (0000882095) (Filer) | 2026-05-07 | English |
Browse filings by year
17 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 46691604 | FORM 8-K | 2026-05-20 | English | ||
| 46459832 | 424B5 | 2026-05-18 | English | ||
| 46273906 | FWP | 2026-05-14 | English | ||
| 46012309 | 424B5 | 2026-05-14 | English | ||
| 46151278 | Regulatory Filings 2026 | 2026-05-08 | English | ||
| 43582483 | S-8 - GILEAD SCIENCES, INC. (0000882095) (Filer) | 2026-05-07 | English | ||
| 43582866 | 10-Q - GILEAD SCIENCES, INC. (0000882095) (Filer) | 2026-05-07 | English | ||
| 43481120 | 8-K - GILEAD SCIENCES, INC. (0000882095) (Filer) | 2026-05-07 | English | ||
| 46151281 | FORM 8-K | 2026-05-04 | English | ||
| 46151286 | Major Shareholding Notification 2026 | 2026-04-30 | English | ||
| 46151283 | Major Shareholding Notification 2026 | 2026-04-28 | English | ||
| 38002356 | 8-K - GILEAD SCIENCES, INC. (0000882095) (Filer) | 2026-04-28 | English | ||
| 33065533 | 144 - GILEAD SCIENCES, INC. (0000882095) (Subject) | 2026-03-27 | English | ||
| 33053040 | SCHEDULE 13G/A - GILEAD SCIENCES, INC. (0000882095) (Subject) | 2026-03-26 | English | ||
| 33001942 | ARS - GILEAD SCIENCES, INC. (0000882095) (Filer) | 2026-03-20 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
LIFECORE BIOMEDICAL, INC. \DE\
A CDMO for sterile injectables and producer of non-animal-s…
|
LFCR | US | Manufacturing |
|
Liminatus Pharma, Inc.
A pre-clinical biopharma company developing immune-modulati…
|
LIMN | US | Manufacturing |
|
Lincoln Pharmaceuticals ltd.
Develops, manufactures, and markets diverse therapeutic for…
|
LINCOLN | IN | Manufacturing |
|
Lineage Cell Therapeutics Inc.
Develops allogeneic cell therapies from stem cells for dege…
|
LCTX | US | Manufacturing |
|
Lionco Pharmaceutical Group Co.,Ltd.
Develops and produces chemical drug preparations and high-e…
|
603669 | CN | Manufacturing |
|
Lipidor AB
A former developer of topical skin medications using a spra…
|
LIPI | SE | Manufacturing |
|
Lipocine Inc.
Develops treatments for metabolic, endocrine, and CNS disor…
|
LPCN | US | Manufacturing |
|
Liquidia Corp
Biopharmaceutical company developing therapies for rare car…
|
LQDA | US | Manufacturing |
|
Lir Life Sciences Corp.
Developing scalable, affordable transdermal and alternative…
|
SKNY | CA | Manufacturing |
|
LISATA THERAPEUTICS, INC.
Develops therapies to enhance anti-cancer drug delivery to …
|
LSTA | US | Manufacturing |
GILEAD SCIENCES, INC. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/29828/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=29828 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=29828 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=29828 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 29828}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for GILEAD SCIENCES, INC. (id: 29828)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.